InsuletMEX:PODD 79 Median PS Value is MXN7,150.80 as of Jun. 26, 2026, which is 100% below its 10-year median of 1.37. GuruFocus rates MEX:PODD with a GF Score™ of 79/100 and a GF Value™ of MXN6,546.87 (Significantly Undervalued). Among 338 Medical Devices & Instruments companies, Insulet ranks better than 82.84% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Insulet's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN751.715. Insulet's 10-Year median PS Ratio is 9.5126. Therefore, the Median PS Value for today is MXN7,150.80.
As of today (2026-06-26), Insulet's share price is MXN2548.13. Insulet's Median PS Value is MXN7,150.80. Therefore, Insulet's Price to Median PS Value for today is 0.36.
The historical rank and industry rank for Insulet's Median PS Value or its related term are showing as below:
MEX:PODD'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.36 Med: 1.37 Max: 2.28
Current: 0.36
During the past 13 years, the highest Price to Median PS Value of Insulet was 2.28. The lowest was 0.36. And the median was 1.37.
MEX:PODD's Price-to-Median-PS-Value is ranked better than 82.84% of 338
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs MEX:PODD: 0.36
Insulet (MEX:PODD) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Insulet's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2548.13
/
7,150.80
=
0.36
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insulet Median PS Value Related Terms
Insulet Median PS Value Historical Data
* Premium members only.
The historical data trend for Insulet's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:PODD vs MASI, BRKR, GMED: Median PS Value Comparison
For the Medical Devices subindustry, Insulet's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insulet Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Insulet's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 9.5126.
Insulet's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN751.715.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insulet (MEX:PODD) has a Median PS Value of MXN7,150.80 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Insulet and its competitors. This is 521856% above median its historical median of 1.37. Over the past decade, Insulet's Median PS Value has ranged from 0.36 to 2.28. According to the industry distribution chart, Insulet ranks #58 out of 338 companies in the Medical Devices & Instruments industry, placing it in the top 17.2%.
Is Insulet's Median PS Value too high?
Insulet's current Median PS Value of MXN7,150.80 is 521856% above median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 2.28. Based on the distribution chart, Insulet ranks #58 out of 338 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Insulet has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Insulet's Median PS Value compare to MASI and BRKR?
According to the Medical Devices & Instruments industry distribution chart, Insulet ranks #58 out of 338 companies for Median PS Value. This places Insulet in the top 17% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, Insulet's own Median PS Value has ranged from 0.36 to 2.28 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Insulet and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Insulet's current Median PS Value is MXN7,150.80, which is 521856% above median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insulet stock overvalued right now?
Based on GuruFocus' analysis, Insulet (MEX:PODD) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN6,546.87, compared to a current price of MXN2,548.13 — trading 61.1% below its estimated fair value. The current Median PS Value is MXN7,150.80, which is 521856% above median its 10-year median of 1.37. Insulet's overall GF Score™ is 79/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Insulet (MEX:PODD), the current Median PS Value is MXN7,150.80 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Insulet (MEX:PODD) Overvalued in 2026?
Based on GuruFocus' analysis, Insulet stock appears to be undervalued.
The current stock price of MXN2,548.13 is trading 61.1% below its estimated GF Value™ of MXN6,546.87.
GuruFocus considers Insulet to be Significantly Undervalued.
Key valuation signals for MEX:PODD:
Median PS Value: MXN7,150.80 (521856% above median its 10-year median of 1.37)
GF Value™: MXN6,546.87 vs. price of MXN2,548.13 (61.1% below fair value)
No single metric tells the full story. See the MEX:PODD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
79GF Score
Get the complete analysis for MEX:PODD
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PODD has been successfully added to your 
